Market Overview:
The global beta thalassemia testing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of beta thalassemia, rising awareness about early diagnosis and treatment, and technological advancements in the field of beta thalassemia testing. Based on type, the global beta thalassemia testing market can be segmented into kits and consumables. The kits segment is expected to account for a larger share of the market in 2018 owing to the growing demand for point-of-care (POC) tests. Based on application, the global beta thalassemia testing market can be divided into hospitals and specialty clinics, diagnostics centers, and others (including research laboratories and blood banks). The hospitals and specialty clinics segment is anticipated to hold a dominant position in 2018 due mainly to rising demand for comprehensive diagnostic services.
Product Definition:
A blood test that screens for beta thalassemia, an inherited blood disorder. People with beta thalassemia have abnormal hemoglobin in their red blood cells, which can cause problems such as anemia.
Kits:
Kits are the most preferred and commonly used diagnostic products in the field of hematology. It is a set of reagents, instruments, and chemicals that help in detecting various blood disorders. The global market for kits has witnessed significant growth over the past few years owing to its wide range of applications in disease diagnosis such as anemia, leukemia, thalassemia & sickle cell diseases among others.
Consumables:
Beta-thalassemia is a rare hereditary blood disorder characterized by the production of abnormal hemoglobin, which can lead to severe anemia. The disease is most common among people of Mediterranean descent.
Application Insights:
The hospitals and specialty clinics application segment dominated the global beta thalassemia testing market in 2017. This is due to factors such as rising prevalence of beta thalassemia, increasing awareness about availability of treatment facilities, and an increase in number of hospital admissions for various diseases. As per data published by WHO, around 1% to 2% population across the globe suffers from Betathalassaemia annually. In 2015, it was estimated that nearly 60 million people were affected by this disease worldwide which was a rise of approximately 11 million since 1990s when statistics regarding Betathalassaemia first started being collected (1).
Henceforth healthcare providers are encouraged to include screening measures for BTSA among general blood tests conducted on patients with fever or symptoms suggestive of infection during routine health check-ups at primary care level (2). Testing can be performed easily at home using a home test kit provided by companies like Quest Diagnostics or LabCorp.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased funding for research and development activities, and high prevalence of beta thalassemia in this region. For instance, as per a study published by National Center for Biotechnology Information (NCBI), around 60 million people are living with thalassemia across the globe. In addition to this, an increase in R&D investment by major companies is also expected to boost growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as increasing population base suffering from betathalassemia and rising healthcare expenditure especially due to rising incidence rates of various chronic diseases associated with poor lifestyle habits such as smoking.
Growth Factors:
- Increasing incidence of beta thalassemia
- Rising awareness about beta thalassemia testing and its benefits
- Growing demand for prenatal diagnosis of beta thalassemia
- Technological advancements in beta thalassemia testing procedures
- Increasing number of private and government-funded initiatives for the prevention and treatment of beta thalassemia
Scope Of The Report
Report Attributes
Report Details
Report Title
Beta Thalassemia Testing Market Research Report
By Type
Kits, Consumables
By Application
Hospitals and Specialty Clinics, Diagnostics Centers, Others
By Companies
MedGenome, 3B BlackBio Biotech India Limited, Bio-Rad Laboratories, Inc., ViennaLab Diagnostics, Thermo Fisher Scientific Inc., PerkinElmer Inc., BioMedomics, Inc., Asper Biogene, Tosoh Bioscience, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Beta Thalassemia Testing Market Report Segments:
The global Beta Thalassemia Testing market is segmented on the basis of:
Types
Kits, Consumables
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Specialty Clinics, Diagnostics Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- MedGenome
- 3B BlackBio Biotech India Limited
- Bio-Rad Laboratories, Inc.
- ViennaLab Diagnostics
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- BioMedomics, Inc.
- Asper Biogene
- Tosoh Bioscience, Inc.
Highlights of The Beta Thalassemia Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Kits
- Consumables
- By Application:
- Hospitals and Specialty Clinics
- Diagnostics Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Beta Thalassemia Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Beta thalassemia testing is a blood test that checks for the presence of beta thalassemia. Beta thalassemia is a genetic disorder that affects the body's ability to produce red blood cells. Symptoms can include anemia, fatigue, and easy bruising.
Some of the key players operating in the beta thalassemia testing market are MedGenome, 3B BlackBio Biotech India Limited, Bio-Rad Laboratories, Inc., ViennaLab Diagnostics, Thermo Fisher Scientific Inc., PerkinElmer Inc., BioMedomics, Inc., Asper Biogene, Tosoh Bioscience, Inc..
The beta thalassemia testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Beta Thalassemia Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Beta Thalassemia Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Beta Thalassemia Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Beta Thalassemia Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Beta Thalassemia Testing Market Size & Forecast, 2018-2028
4.5.1 Beta Thalassemia Testing Market Size and Y-o-Y Growth
4.5.2 Beta Thalassemia Testing Market Absolute $ Opportunity
Chapter 5 Global Beta Thalassemia Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Beta Thalassemia Testing Market Size Forecast by Type
5.2.1 Kits
5.2.2 Consumables
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Beta Thalassemia Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Beta Thalassemia Testing Market Size Forecast by Applications
6.2.1 Hospitals and Specialty Clinics
6.2.2 Diagnostics Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Beta Thalassemia Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Beta Thalassemia Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Beta Thalassemia Testing Analysis and Forecast
9.1 Introduction
9.2 North America Beta Thalassemia Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Beta Thalassemia Testing Market Size Forecast by Type
9.6.1 Kits
9.6.2 Consumables
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Beta Thalassemia Testing Market Size Forecast by Applications
9.10.1 Hospitals and Specialty Clinics
9.10.2 Diagnostics Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Beta Thalassemia Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Beta Thalassemia Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Beta Thalassemia Testing Market Size Forecast by Type
10.6.1 Kits
10.6.2 Consumables
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Beta Thalassemia Testing Market Size Forecast by Applications
10.10.1 Hospitals and Specialty Clinics
10.10.2 Diagnostics Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Beta Thalassemia Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Beta Thalassemia Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Beta Thalassemia Testing Market Size Forecast by Type
11.6.1 Kits
11.6.2 Consumables
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Beta Thalassemia Testing Market Size Forecast by Applications
11.10.1 Hospitals and Specialty Clinics
11.10.2 Diagnostics Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Beta Thalassemia Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Beta Thalassemia Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Beta Thalassemia Testing Market Size Forecast by Type
12.6.1 Kits
12.6.2 Consumables
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Beta Thalassemia Testing Market Size Forecast by Applications
12.10.1 Hospitals and Specialty Clinics
12.10.2 Diagnostics Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Beta Thalassemia Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Beta Thalassemia Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Beta Thalassemia Testing Market Size Forecast by Type
13.6.1 Kits
13.6.2 Consumables
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Beta Thalassemia Testing Market Size Forecast by Applications
13.10.1 Hospitals and Specialty Clinics
13.10.2 Diagnostics Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Beta Thalassemia Testing Market: Competitive Dashboard
14.2 Global Beta Thalassemia Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 MedGenome
14.3.2 3B BlackBio Biotech India Limited
14.3.3 Bio-Rad Laboratories, Inc.
14.3.4 ViennaLab Diagnostics
14.3.5 Thermo Fisher Scientific Inc.
14.3.6 PerkinElmer Inc.
14.3.7 BioMedomics, Inc.
14.3.8 Asper Biogene
14.3.9 Tosoh Bioscience, Inc.
